{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T01:13:58Z","timestamp":1773710038324,"version":"3.50.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,3,24]],"date-time":"2019-03-24T00:00:00Z","timestamp":1553385600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology: X"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.eurox.2019.100015","type":"journal-article","created":{"date-parts":[[2019,4,20]],"date-time":"2019-04-20T10:49:21Z","timestamp":1555757361000},"page":"100015","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Is there evidence for efficacy of human papillomavirus vaccination in solid organ transplant recipients?"],"prefix":"10.1016","volume":"4","author":[{"given":"Emeline","family":"Vinkenes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martine A.","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3726-0589","authenticated-orcid":false,"given":"Jan","family":"Blaakaer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eurox.2019.100015_bib0005","series-title":"Human papillomavirus (HPV) and cervical cancer","year":"2019"},{"issue":"136","key":"10.1016\/j.eurox.2019.100015_bib0010","first-page":"E359","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","author":"Ferlay","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.eurox.2019.100015_bib0015","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a014985","article-title":"Why is organ transplantation clinically important?","volume":"3","author":"Griny\u00f3","year":"2013","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.eurox.2019.100015_bib0020","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/00000658-200010000-00004","article-title":"Long-term survival after liver transplantation in 4.000 consecutive patients at a single center","volume":"232","author":"Jain","year":"2000","journal-title":"Ann Surg"},{"key":"10.1016\/j.eurox.2019.100015_bib0025","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0140-6736(07)61050-2","article-title":"Incidence of cancers in people with HIV\/AIDS compared with immunosuppressed transplant recipients: a meta-analysis","volume":"370","author":"Grulich","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.eurox.2019.100015_bib0030","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1111\/ajt.12472","article-title":"HPV-related cancers after solid organ transplantation in the United States","volume":"13","author":"Madeleine","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.eurox.2019.100015_bib0035","series-title":"Gardasil 9 vaccine protects against additional HPV types","year":"2017"},{"key":"10.1016\/j.eurox.2019.100015_bib0040","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S1470-2045(11)70286-8","article-title":"Overall efficacy of HPV-16\/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial","volume":"13","author":"Lehtinen","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.eurox.2019.100015_bib0045","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0140-6736(09)61248-4","article-title":"Efficacy of human papillomavirus (HPV)-16\/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women","volume":"374","author":"Paavonen","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.eurox.2019.100015_bib0050","doi-asserted-by":"crossref","first-page":"c3493","DOI":"10.1136\/bmj.c3493","article-title":"Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial","volume":"341","author":"Dillner","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.eurox.2019.100015_bib0055","first-page":"915","article-title":"Incidence of cervical lesions in Danish women before and after implementation of a national HPV vaccination program","volume":"25","author":"Baldur-Felskov","year":"2014","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.eurox.2019.100015_bib0060","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1080\/21645515.2015.1039208","article-title":"Immunization of children with secondary immunodeficiency","volume":"11","author":"Esposito","year":"2015","journal-title":"Hum Vaccin Immunother"},{"issue":"SUPPL. 3","key":"10.1016\/j.eurox.2019.100015_bib0065","doi-asserted-by":"crossref","first-page":"S140","DOI":"10.1016\/j.vaccine.2006.05.120","article-title":"HPV vaccines in immunocompromised women and men","volume":"24","author":"Palefsky","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.eurox.2019.100015_bib0070","series-title":"PRISMA (Preferred reporting items for systematic reviews and meta-analyses) checklist","year":"2017"},{"key":"10.1016\/j.eurox.2019.100015_bib0075","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/petr.12226","article-title":"Immunogenicity of a prophylactic quadrivalent human papillomavirus L1 virus-like particle vaccine in male and female adolescent transplant recipients","volume":"18","author":"Gomez-Lobo","year":"2014","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.eurox.2019.100015_bib0080","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1111\/ajt.12329","article-title":"Immunogenicity of quadrivalent human papillomavirus vaccine in organ transplant recipients","volume":"13","author":"Kumar","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.eurox.2019.100015_bib0085","doi-asserted-by":"crossref","first-page":"776","DOI":"10.2215\/CJN.09690915","article-title":"Immunogenicity of human papillomavirus recombinant vaccine in children with CKD","volume":"11","author":"Nelson","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.eurox.2019.100015_bib0090","first-page":"80","article-title":"The response to human papillomavirus vaccination in pediatric patients before and after kidney transplantation","volume":"19","author":"Nailescu","year":"2015","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.eurox.2019.100015_bib0095","series-title":"Search: human papilloma virus vaccine | transplant","year":"2017"},{"key":"10.1016\/j.eurox.2019.100015_bib0100","series-title":"Use of a 2-Dose schedule for human papillomavirus vaccination - updated recommendations of the advisory committee on immunization practices","year":"2017"},{"issue":"58","key":"10.1016\/j.eurox.2019.100015_bib0105","first-page":"3022","article-title":"IDSA clinical practice guideline for vaccination of the immunocompromised host","volume":"2014","author":"Rubin","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eurox.2019.100015_bib0110","series-title":"Canadian immunization guide: part 3 - vaccination of specific populations","first-page":"8","year":"2017"},{"key":"10.1016\/j.eurox.2019.100015_bib0115","series-title":"3.3 Groups with special vaccination requirements","year":"2017"},{"key":"10.1016\/j.eurox.2019.100015_bib0120","series-title":"Immunisation of immunocompromised persons","year":"2015"},{"key":"10.1016\/j.eurox.2019.100015_bib0125","series-title":"Table 1: summary of WHO position papers - recommendations for routine immunization","year":"2017"},{"key":"10.1016\/j.eurox.2019.100015_bib0130","series-title":"Gardasil product insert 9682302. Merck GmbH","author":"GmbH","year":"2006"},{"key":"10.1016\/j.eurox.2019.100015_bib0135","series-title":"CASP cohort study checklistm","year":"2017"},{"key":"10.1016\/j.eurox.2019.100015_bib0140","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/S0140-6736(09)60691-7","article-title":"Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trial","volume":"373","author":"Munoz","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.eurox.2019.100015_bib0145","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1056\/NEJMoa0909537","article-title":"Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males","volume":"364","author":"Giuliano","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eurox.2019.100015_bib0150","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1056\/NEJMoa061760","article-title":"Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases","volume":"356","author":"Garland","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eurox.2019.100015_bib0155","first-page":"959","article-title":"Optimization and validation of a multiplexed luminex assay to quantify antibodies to neutralizing epitopes on human papillomaviruses 6, 11, 16, and 18","volume":"12","author":"Dias","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.eurox.2019.100015_bib0160","series-title":"Questions and answers on the HPV vaccine","year":"2017"},{"key":"10.1016\/j.eurox.2019.100015_bib0165","series-title":"Statement on the human papillomavirus (HPV) vaccine","year":"2017"},{"key":"10.1016\/j.eurox.2019.100015_bib0170","series-title":"Canadian immunization guide: part 4 - active vaccines","first-page":"9","year":"2017"},{"key":"10.1016\/j.eurox.2019.100015_bib0175","series-title":"4.6 Human papillomavirus","year":"2017"},{"key":"10.1016\/j.eurox.2019.100015_bib0180","series-title":"Chapter 10 Human papillomavirus","year":"2016"},{"key":"10.1016\/j.eurox.2019.100015_bib0185","series-title":"Human papillomavirus (HPV) vaccine safety","year":"2017"},{"issue":"Suppl 4","key":"10.1016\/j.eurox.2019.100015_bib0190","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/ajt.12122","article-title":"Vaccination in solid organ transplantation","volume":"13","author":"Danziger-Isakov","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.eurox.2019.100015_bib0195","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1097\/00007890-200006150-00042","article-title":"Influenza vaccination does not promote cellular or humoral activation among heart transplant recipients","volume":"69","author":"Kimball","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.eurox.2019.100015_bib0200","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1111\/j.1600-6143.2004.00564.x","article-title":"Influenza vaccination in orthotopic liver transplant recipients: absence of post administration ALT elevation","volume":"4","author":"Lawal","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.eurox.2019.100015_bib0205","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1001\/jama.2013.1625","article-title":"Immunogenicity of 2 doses of HPV vaccine in younger adolescents vs 3 doses in young women: a randomized clinical trial","volume":"309","author":"Dobson","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.eurox.2019.100015_bib0210","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/tid.12322","article-title":"Human papillomavirus-related high-grade squamous intraepithelial lesions of the esophagus, skin, and cervix in an adolescent lung transplant recipient: a case report and literature review","volume":"17","author":"Freiberger","year":"2015","journal-title":"Transpl Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.eurox.2019.100015_bib0215","first-page":"S1","article-title":"Recommendations for the outpatient surveillance of renal transplant recipients","volume":"11","author":"Kasiske","year":"2000","journal-title":"Am Soc Transplant J Am Soc Nephrol"},{"key":"10.1016\/j.eurox.2019.100015_bib0220","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1432-2277.2009.00975.x","article-title":"Skin cancer and (pre)malignancies of the female genital tract in renal transplant recipients","volume":"23","author":"Meeuwis","year":"2010","journal-title":"Transpl Int"},{"key":"10.1016\/j.eurox.2019.100015_bib0225","series-title":"Epi-nyt","year":"2017"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology: X"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590161319300493?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590161319300493?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T02:56:40Z","timestamp":1762916200000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590161319300493"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":45,"alternative-id":["S2590161319300493"],"URL":"https:\/\/doi.org\/10.1016\/j.eurox.2019.100015","relation":{},"ISSN":["2590-1613"],"issn-type":[{"value":"2590-1613","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is there evidence for efficacy of human papillomavirus vaccination in solid organ transplant recipients?","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology: X","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eurox.2019.100015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100015"}}